Search

everythinglearnresearchcommunity

for

Search:↓

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Spironolactone helps regrow hair in women with hair loss.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Human enzymes can detoxify harmful substances but might also increase their cancer risk.

Spironolactone plus finasteride reduces hirsutism more effectively.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

A systematic approach is crucial for managing hair loss in women.

Hormonal therapies are safe and effective for treating adult women's acne.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Certain hormone treatments can improve acne and related conditions in women.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.